Guido Boerrigter, John C Burnett. Show Affiliations »
Abstract
Mesh: See more » Benzoates/pharmacologyBenzoates/therapeutic useClinical Trials as TopicEndothelium, Vascular/drug effectsEnzyme Activation/drug effectsGuanylate Cyclase/physiologyHeart Failure/drug therapyHeart Failure/enzymologyHeme/physiologyHumansMorpholines/pharmacologyNitric Oxide/physiologyPyrazoles/pharmacologyPyridines/pharmacologyPyrimidines/pharmacologyReceptors, Cytoplasmic and Nuclear/physiologySignal Transduction/physiologySoluble Guanylyl CyclaseVasodilator Agents/pharmacologyVasomotor System/physiology
Substances: See more » 3-(4-Amino-5-cyclopropylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo(3,4-b)pyridineBAY 41-8543BenzoatesMorpholinesPyrazolesPyridinesPyrimidinesReceptors, Cytoplasmic and NuclearVasodilator AgentsNitric OxideBAY 58-2667HemeGuanylate CyclaseSoluble Guanylyl Cyclase
Year: 2009 PMID: 19451346 DOI: 10.1161/CIRCULATIONAHA.109.860288
Source DB: PubMed Journal: Circulation ISSN: 0009-7322 Impact factor: 29.690